Picture of Adherium logo

ADR — Adherium News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Adherium Receives U.S. FDA Clearance For GSK PMDI Inhaler Users To Remotely Monitor Physiological Parameters

Nov 28 (Reuters) - Adherium Ltd  ADR.AX :
    * RECEIVED U.S. FDA CLEARANCE FOR GSK PMDI INHALER USERS TO
REMOTELY MONITOR PHYSIOLOGICAL PARAMETERS

Source text for Eikon:  ID:nASX1DyfGG 
Further company coverage:  ADR.AX 
 (Reporting by Poonam Behura)
 ((Poonam.Behura@thomsonreuters.com;))

Recent news on Adherium

See all news